Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review - Scorecard - MDSpire

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

  • By

  • Yang Zhao

  • Zhizhuo Huang

  • Lian Xue

  • Leping Zhang

  • Yueping Jia

  • May 12, 2026

  • 0 min

Share

Clinical Scorecard: Detection of an NFIA::CBFA2T3 Fusion in Cerebrospinal Fluid Validates the Diagnosis of Pediatric CNS Myeloid Sarcoma with Erythroid Differentiation: A Case Study and Review of the Literature

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationChildren with myeloid sarcoma and erythroid differentiation
Care Setting

Key Highlights

  • Significance of NFIA::CBFA2T3 fusion in diagnosis

Guideline-Based Recommendations

Diagnosis

  • Include specific molecular genetic tests recommended for diagnosis

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Include specific therapies used in the case

        Clinical Best Practices

        • interdisciplinary_approach

        Related Resources & Content

        Original Source(s)

        Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

        • by Yang Zhao, Zhizhuo Huang, Lian Xue, Leping Zhang, Yueping Jia

        • May 12, 2026

        Related Content

        Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

        Biotech exec Jeremy Levin on the industry’s strategic turning point

        FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series